ARS Pharmaceuticals Inc - SPRY - stock price prediction, stock price target, analyst ratings from 6 analysts
ARS Pharmaceuticals Inc has a share price target of US$ 30, revenue growth forecast of -6.8%, and profit growth estimate of -1839.0% for FY25, based on top 6 analyst calls.